Boston, MA · Founded 2022 · Privately Held (backing)
Developer of gene expression analysis technology designed to study optically extract multi-omic information from biological tissue. Stellaromics is based in Boston, MA and was founded in 2022. Its last reported valuation was $163 million in Dec 2024. It has raised $105 million.
Last reported valuation
$163.0M
Oct 2026
Priced at
—
Total raised
$105.0M
Last round
—
No prints on record
No secondary trades in Stellaromics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Stellaromics with a free account
·Watch Stellaromics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Stellaromics stock.
